We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$1.69B
AUM Growth
+$80.8M
Cap. Flow
-$11.1M
Cap. Flow %
-0.66%
Top 10 Hldgs %
52.24%
Holding
26
New
1
Increased
3
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$71.8M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.51M
3
TSM icon
TSMC
TSM
+$7.13M
4
BABA icon
Alibaba
BABA
+$6.12M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$62.3M
2
CL icon
Colgate-Palmolive
CL
+$10.7M
3
ZTS icon
Zoetis
ZTS
+$9.46M
4
ECL icon
Ecolab
ECL
+$4.73M
5
MA icon
Mastercard
MA
+$1.68M

Sector Composition

Rank Sector Weight
1 Financials 22.26%
2 Healthcare 19.28%
3 Communication Services 19.19%
4 Technology 17.41%
5 Industrials 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$477B
$115M 6.78%
433,153
-6,714
-2% -$1.68M
CME icon
2
CME Group
CME
$92.2B
$93.6M 5.54%
481,998
-7,306
-1% -$1.35M
META icon
3
Meta Platforms (Facebook)
META
$1.51T
$89.7M 5.31%
464,818
-2,822
-0.6% -$516K
CMCSA icon
4
Comcast
CMCSA
$79.1B
$87.5M 5.18%
2,069,380
-29,655
-1% -$1.25M
ZTS icon
5
Zoetis
ZTS
$31.6B
$85.7M 5.07%
755,119
-90,303
-11% -$9.46M
WP
6
DELISTED
Worldpay, Inc.
WP
$85.6M 5.07%
698,457
-10,023
-1% -$1.19M
AAPL icon
7
Apple
AAPL
$4.89T
$85.6M 5.07%
1,729,472
-25,680
-1% -$1.25M
DHR icon
8
Danaher
DHR
$135B
$82.3M 4.87%
649,743
-9,475
-1% -$1.12M
TSM icon
9
TSMC
TSM
$2.09T
$79.4M 4.7%
2,026,298
+173,270
+9% +$7.13M
SPGI icon
10
S&P Global
SPGI
$126B
$78.5M 4.65%
344,806
-4,777
-1% -$1.04M
BABA icon
11
Alibaba
BABA
$269B
$77.8M 4.61%
459,319
+35,444
+8% +$6.12M
ALLE icon
12
Allegion
ALLE
$13B
$77.7M 4.6%
702,483
-10,632
-1% -$1.06M
BDX icon
13
Becton Dickinson
BDX
$43.1B
$76M 4.5%
+309,192
New +$71.8M
SCHW
14
Charles Schwab
SCHW
$177B
$75.4M 4.46%
1,876,410
-26,620
-1% -$1.16M
ANSS
15
DELISTED
Ansys
ANSS
$66.8M 3.96%
326,326
-5,848
-2% -$1.11M
GOOG icon
16
Alphabet (Google) Class C
GOOG
$3.9T
$63.6M 3.76%
1,176,280
-11,660
-1% -$673K
ACN icon
17
Accenture
ACN
$89.9B
$62.4M 3.69%
337,565
-5,204
-2% -$935K
EA icon
18
Electronic Arts
EA
$52.4B
$56.3M 3.33%
555,930
-8,056
-1% -$767K
CL icon
19
Colgate-Palmolive
CL
$72.6B
$50.1M 2.96%
698,688
-150,341
-18% -$10.7M
ECL icon
20
Ecolab
ECL
$75.6B
$45.9M 2.72%
232,499
-25,441
-10% -$4.73M
BIO icon
21
Bio-Rad Laboratories Class A
BIO
$8.42B
$44.2M 2.61%
141,241
+25,066
+22% +$7.51M
WST icon
22
West Pharmaceutical
WST
$23.1B
$37.4M 2.21%
298,940
-4,051
-1% -$478K
WBT
23
DELISTED
Welbilt, Inc.
WBT
$32.2M 1.9%
1,926,677
-30,132
-2% -$493K
TV icon
24
Televisa
TV
$1.45B
$27.2M 1.61%
3,217,243
-48,651
-1% -$474K
HDB icon
25
HDFC Bank
HDB
$119B
$13.8M 0.82%
426,024
– –
1
2

Similar funds

CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return

Intermede Investment Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Intermede Investment Partners held 26 positions worth $1.69B, up 5% from $1.61B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Intermede Investment Partners's Q2 2019 filing shows 1 new, 3 increased, 20 reduced and 1 closed positions. Its largest new stake was Becton Dickinson: 309,192 shares worth $76M. The largest sale was Allergan plc, an estimated $62.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Communication Services.

  • Intermede Investment Partners's largest Q2 2019 buy was Becton Dickinson: 309,192 shares worth $76M.
  • Intermede Investment Partners added most to Bio-Rad Laboratories Class A in Q2 2019, an estimated $7.51M increase.
  • Intermede Investment Partners's biggest Q2 2019 reduction was Colgate-Palmolive, cutting an estimated $10.7M.
  • Intermede Investment Partners fully exited Allergan plc in Q2 2019, selling an estimated $62.3M.
  • Intermede Investment Partners's ten largest holdings make up 52% of its $1.69B portfolio in Q2 2019.
  • Intermede Investment Partners opened 1 new position and closed 1 in Q2 2019.
  • Intermede Investment Partners's portfolio value rose 5% quarter-over-quarter to $1.69B.

Based on Intermede Investment Partners's 13F filing for Q2 2019, filed 30 Jul 2019.